The DOI matches its Crossref record.
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
Abstract
The current World Health Organization (WHO) classification of hematopoietic malignancies defines several types of mature T-cell leukemia including T-cell prolymphocytic leukemia (T-PLL), Sezary syndrome (SS), and T-cell large granular lymphocytic (T-LGL) leukemia. These neoplasms can show overlapping features with each other and with T-cell lymphomas involving peripheral blood (PB). We analyzed the spectrum of clinicopatho-logic features in 102 mature T-cell leukemias and compared them to 10 hepatosplenic T-cell lymphomas that involved PB. T-PLL, defined as a T-cell leukemia showing rapidly rising PB lymphocyte counts, was the only tumor type expressing the oncoprotein TCL1 (71% of cases) and could present with relatively low lymphocyte levels or small tumor cell morphology. SS, defined by accompanying erythrodermic skin disease, was frequently associated with peripheral eosinophilia but could also develop high numbers of prolymphocytes, especially late in the disease course. T-LGL leukemia, defined by accompanying cytopenias or autoimmune phenomena (or both), had the best clinical outcome and generally showed the lowest circulating lymphocyte levels with only a few cases developing marked lymphocytosis. Using the dominant clinical or phenotypic feature, we describe here the degree of overlap among currently recognized WHO categories and identify areas where further clarification is needed. Our results indicate that incorporation of additional criteria, such as TCL1 expression status and hematologic parameters, can assist in a more accurate classification. (Blood. 2004;104:328-335)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Herling, M., Patel, K. A., Khalili, J., Schlette, E., Kobayashi, R., Medeiros, L. J., & Jones, D. (2006) · Leukemia · doi:10.1038/sj.leu.2404017 · Cited by 123
Self-citationDevelopment of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
Toutah, K., Nawar, N., Timonen, S., Sorger, H., Raouf, Y. S., Bukhari, S., von Jan, J., Ianevski, A., Gawel, J. M., Olaoye, O. O., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00420 · Cited by 51
Self-citationNoncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia
Braun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1908 · Cited by 14
Self-citationBraun, T., Stachelscheid, J., Bley, N., Oberbeck, S., Otte, M., Müller, T. A., Wahnschaffe, L., Glaß, M., Ommer, K., Franitza, M., et al. (2023) · doi:10.1158/0008-5472.c.6513796
Self-citation
Metadata
- Authors
- Herling, M., Khoury, J. D., Washington, L. T., Duvic, M., Keating, M. J., & Jones, D.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-07-15
- Volume
- 104
- Issue
- 2
- Pages
- 328-335
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2094034152
- Cited by
- 205
- References
- 0
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. https://app.cochat.ai/papers/10.1182/blood-2004-01-0002
- The paper
- Herling, M., Khoury, J. D., Washington, L. T., Duvic, M., Keating, M. J., & Jones, D. (2004). A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. https://doi.org/10.1182/blood-2004-01-0002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.